Please assess the completion status of the following clinical trial:

Trial Title: TXA and Corona Virus 2019 (COVID19) in Outpatients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Positive COVID-19 test~* Outpatient~* Age \>/= 19 y.o.~Exclusion Criteria:~* Allergic reaction to tranexamic acid~* History of hypercoagulation disorders (deep venous thrombosis, pulmonary thromboembolism)~* Ongoing anticoagulation~* History of GI bleeding~* History of Seizures~* Cardiac or other vascular stents~* History of severe renal disease~* History of intracranial hemorrhage

- Gender: ALL
- Minimum Age: 19 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Tranexamic Acid Treatment (Type: EXPERIMENTAL): None
- Placebo Treatment (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).